NASDAQ: ASND
Ascendis Pharma A Stock Ownership - Who owns Ascendis Pharma A?

Insider buying vs selling

Have Ascendis Pharma A insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ASND insiders and whales buy or sell their stock.

ASND Shareholders

What type of owners hold Ascendis Pharma A stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP16.66%10,112,744$1.68BInstitution
Westfield Capital Management Co LP9.11%5,528,239$920.89MInstitution
Avoro Capital Advisors LLC8.41%5,103,055$850.07MInstitution
Fmr LLC7.79%4,728,647$787.70MInstitution
Artisan Partners Limited Partnership7.33%4,450,420$741.35MInstitution
Janus Henderson Group PLC7.22%4,380,382$729.68MInstitution
Capital International Investors4.72%2,863,249$476.96MInstitution
T Rowe Price Investment Management Inc4.49%2,725,546$454.02MInstitution
Price T Rowe Associates Inc3.76%2,283,207$380.34MInstitution
Massachusetts Financial Services Co3.08%1,867,551$311.10MInstitution

1 of 3

ASND vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ASND100.00%0.00%
EXEL89.31%5.19%Net SellingNet Selling
MRNA71.65%22.83%Net SellingNet Buying
INCY76.18%23.82%Net SellingNet Selling
BMRN95.98%1.72%Net SellingNet Selling

Ascendis Pharma A Stock Ownership FAQ

Who owns Ascendis Pharma A?

Ascendis Pharma A (NASDAQ: ASND) is owned by 105.70% institutional shareholders, 0.00% Ascendis Pharma A insiders, and 0.00% retail investors. Ra Capital Management LP is the largest individual Ascendis Pharma A shareholder, owning 10.11M shares representing 16.66% of the company. Ra Capital Management LP's Ascendis Pharma A shares are currently valued at $1.72B.

If you're new to stock investing, here's how to buy Ascendis Pharma A stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.